Ostarine has been shown to reduce the secretion of leptin and adiponectin from white adipocytes [71], while low levels of leptin can intensify de novo lipogenesis in the liver and promote lipid accumulation in muscles, affecting insulin production in the pancreas and contribute to insulin resistance [72–74]. This evidence concerns the gene ADIPOQ and Insulin resistance.